Screener

Deferred Revenue

Name: Veracyte Deferred Revenue by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Veracyte·Products & Services·1 segment·Rolls up to Contract Liabilities

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Biopharmaceutical and other revenue	$2.2M	$2M	$1.7M	$1.7M	$1.5M	$400K	$1.2M	$700K
Total	—	—	—	—	—	—	—	—

Biopharmaceutical and other revenueView metric